Skip to main content

Table 2 Relationships between NLR–PLR and clinicopathologic characteristics of 305 patients with stage I–II gastric cancer

From: Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer

Characteristic

NLR–PLR

P

0

1

2

Total

120

96

89

 

Age

0.026

 <60 years

77

50

41

 

 ≥60 years

43

46

48

 

Sex

0.735

 Male

81

65

56

 

 Female

39

31

33

 

Tumor location in the stomach

0.029

 Upper third

24

28

35

 

 Middle third

29

15

15

 

 Lower third

67

53

39

 

Tumor size

<0.001

 <3 cm

77

48

31

 

 ≥3 cm

43

48

58

 

TNM stage

0.034

 IA

31

17

8

 

 IB

25

13

15

 

 IIA

16

18

16

 

 IIB

48

48

50

 

mGPS

<0.001

 0

68

57

33

 

 1

10

11

23

 

 2

2

4

7

 

PNI

<0.001

 0

120

94

68

 

 1

0

2

21

 

NLR–PLR

<0.001

 0

114

70

26

 

 1

6

26

46

 

 2

0

0

17

 
  1. mGPS modified glasgow prognostic score, PNI prognostic nutritional index, PLT platelet count, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio